Foreign-Trade Zone 35 -- Philadelphia, Pennsylvania, Expansion of Facilities -- Subzone 35B, Merck & Company, Inc., (Pharmaceutical Products), West Point, Pennsylvania, 74290 [05-24086]

Download as PDF 74290 Federal Register / Vol. 70, No. 240 / Thursday, December 15, 2005 / Notices DEPARTMENT OF COMMERCE Foreign–Trade Zones Board (Docket 61–2005) Foreign–Trade Zone 35 -- Philadelphia, Pennsylvania, Expansion of Facilities -- Subzone 35B, Merck & Company, Inc., (Pharmaceutical Products), West Point, Pennsylvania An application has been submitted to the Foreign–Trade Zones Board (the Board) by the Philadelphia Regional Airport Authority, grantee of FTZ 35, requesting to expand the subzone (Subzone 35B) at the Merck & Company, Inc. (Merck) facility in West Point, Pennsylvania. The application was submitted pursuant to the Foreign– Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board. It was formally filed on December 7, 2005. Subzone 35B was approved by the Board on November 14, 1994 at a single site (106 bldgs./6,317,280 sq. ft. on 405 acres) located at Sunneytown Pike and Broad Street, in West Point (Montgomery County), Pennsylvania, with authority granted for the manufacture of finished pharmaceuticals (Board Order 708, 59 FR 60604, 11/25/94), and expanded on 4/5/01 (Board Order 1153, 66 FR 19918, 4/18/01). Merck is now proposing to expand production capacity under FTZ procedures by adding 168 buildings totaling 1,227,192 sq. ft. but reducing total acreage by 8 acres. The expanded subzone would then include 274 buildings consisting of 7,544,472 sq. ft. on 397 acres. In accordance with the Board’s regulations, a member of the FTZ staff has been designated examiner to investigate the application and report to the Board. Public comment on the application is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at one of the following addresses: 1. Submissions via Express/Package Delivery Services: Foreign–Trade Zones Board, U.S. Department of Commerce, Franklin Court Building–Suite 4100W, 1099 14th Street, NW, Washington, DC 20005; or, 2. Submissions via the U.S. Postal Service: Foreign–Trade Zones Board, U.S. Department of Commerce, FCB–Suite 4100W, 1401 Constitution Avenue, NW, Washington, DC 20230. The closing period for their receipt is February 13, 2006. Rebuttal comments VerDate Aug<31>2005 17:24 Dec 14, 2005 Jkt 208001 in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to February 28, 2006). A copy of the application and accompanying exhibits will be available during this time for public inspection at address Number 1 listed above, and at the U.S. Department of Commerce, Export Assistance Center, The Curtis Center, Suite 580 West, 601 Walnut Street, Independence Square West, Philadelphia, PA 19106. Dated: December 8, 2005. Dennis Puccinelli, Executive Secretary. [FR Doc. 05–24086 Filed 12–14–05; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Foreign–Trade Zones Board (Dockets 62–2005 and 63–2005) Foreign–Trade Zone 61-- San Juan, Puerto Rico, Expansion of Facilities-Subzone 61D, 61E, Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., (Pharmaceutical Products), Arecibo and Barceloneta, Puerto Rico Applications have been submitted to the Foreign–Trade Zones Board (the Board) by the Puerto Rico Trade & Export Company, grantee of FTZ 61, requesting to expand the subzones at the Merck, Sharp & Dohme Quimica de Puerto Rico, Inc. (MSDQ), facilities in Arecibo (Subzone 61D, Docket 62– 2005), and Barceloneta (Subzone 61E, Docket 63–2005), Puerto Rico. The applications were submitted pursuant to the Foreign–Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board. They were formally filed on December 7, 2005. Subzone 61D was approved by the Board on May 12, 1995 at a single site (3 bldgs./286,000 sq. ft. on 38 acres) located at Road PR–2, Km. 60, in the municipality of Arecibo, Puerto Rico, with authority granted for the manufacture of finished pharmaceuticals (Board Order 741, 60 FR 27272, 5/23/95), and expanded on 11/9/00 (Board Order 1125, 65 FR 69731, 11/20/00). MSDQ is now proposing to expand production capacity under FTZ procedures by adding acreage and 1 building and expanding the existing buildings. The expanded subzone would then include 4 buildings consisting of 334,778 sq. ft. on 53 acres. Subzone 61E was approved by the board on May 12, 1995 at a single site (92 bldgs./504,756 sq. ft. on 221 acres) PO 00000 Frm 00002 Fmt 4703 Sfmt 4703 located at Road PR–2, Km. 57, in the municipality of Barceloneta, Puerto Rico, with authority granted for the manufacture of pharmaceutical bulk chemicals and intermediates used in Merck’s human and animal health products and finished animal health and agricultural chemical products for its AgVet Division (agricultural/ veterinary) (Board Order 742, 60 FR 27272, 5/23/95), and expanded on 11/9/ 00 (Board Order 1126, 65 FR 69731, 11/ 20/00). MSDQ is now proposing to expand production capacity under FTZ procedures by adding acreage and 6 buildings and expanding an existing building. The expanded subzone would then include 98 buildings consisting of 598,415 sq. ft. on 257 acres. In accordance with the Board’s regulations, a member of the FTZ staff has been designated examiner to investigate the applications and report to the Board. Public comment on the applications is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at one of the following addresses: 1. Submissions via Express/Package Delivery Services: Foreign–Trade Zones Board, U.S. Department of Commerce, Franklin Court Building–Suite 4100W, 1099 14th Street, NW, Washington, DC 20005; or, 2. Submissions via the U.S. Postal Service: Foreign–Trade Zones Board, U.S. Department of Commerce, FCB–Suite 4100W, 1401 Constitution Avenue, NW, Washington, DC 20230. The closing period for their receipt is February 13, 2006. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to February 28, 2006). A copy of the applications and accompanying exhibits will be available during this time for public inspection at address Number 1 listed above, and at the U.S. Department of Commerce, Export Assistance Center, 525 F.D. Roosevelt Ave., Suite 905, San Juan, PR 00918. Dated: December 8, 2005. Dennis Puccinelli, Executive Secretary. [FR Doc. 05–24084 Filed 12–14–05; 8:45 am] BILLING CODE 3510–DS–S E:\FR\FM\15DEN1.SGM 15DEN1

Agencies

[Federal Register Volume 70, Number 240 (Thursday, December 15, 2005)]
[Notices]
[Page 74290]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24086]



[[Page 74290]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

(Docket 61-2005)


Foreign-Trade Zone 35 -- Philadelphia, Pennsylvania, Expansion of 
Facilities -- Subzone 35B, Merck & Company, Inc., (Pharmaceutical 
Products), West Point, Pennsylvania

    An application has been submitted to the Foreign-Trade Zones Board 
(the Board) by the Philadelphia Regional Airport Authority, grantee of 
FTZ 35, requesting to expand the subzone (Subzone 35B) at the Merck & 
Company, Inc. (Merck) facility in West Point, Pennsylvania. The 
application was submitted pursuant to the Foreign-Trade Zones Act, as 
amended (19 U.S.C. 81a-81u), and the regulations of the Board. It was 
formally filed on December 7, 2005.
    Subzone 35B was approved by the Board on November 14, 1994 at a 
single site (106 bldgs./6,317,280 sq. ft. on 405 acres) located at 
Sunneytown Pike and Broad Street, in West Point (Montgomery County), 
Pennsylvania, with authority granted for the manufacture of finished 
pharmaceuticals (Board Order 708, 59 FR 60604, 11/25/94), and expanded 
on 4/5/01 (Board Order 1153, 66 FR 19918, 4/18/01). Merck is now 
proposing to expand production capacity under FTZ procedures by adding 
168 buildings totaling 1,227,192 sq. ft. but reducing total acreage by 
8 acres. The expanded subzone would then include 274 buildings 
consisting of 7,544,472 sq. ft. on 397 acres.
    In accordance with the Board's regulations, a member of the FTZ 
staff has been designated examiner to investigate the application and 
report to the Board.
    Public comment on the application is invited from interested 
parties. Submissions (original and 3 copies) shall be addressed to the 
Board's Executive Secretary at one of the following addresses:
    1. Submissions via Express/Package Delivery Services: Foreign-Trade 
Zones Board, U.S. Department of Commerce, Franklin Court Building-Suite 
4100W, 1099 14th Street, NW, Washington, DC 20005; or,
    2. Submissions via the U.S. Postal Service: Foreign-Trade Zones 
Board, U.S. Department of Commerce, FCB-Suite 4100W, 1401 Constitution 
Avenue, NW, Washington, DC 20230.
    The closing period for their receipt is February 13, 2006. Rebuttal 
comments in response to material submitted during the foregoing period 
may be submitted during the subsequent 15-day period (to February 28, 
2006).
    A copy of the application and accompanying exhibits will be 
available during this time for public inspection at address Number 1 
listed above, and at the U.S. Department of Commerce, Export Assistance 
Center, The Curtis Center, Suite 580 West, 601 Walnut Street, 
Independence Square West, Philadelphia, PA 19106.

    Dated: December 8, 2005.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. 05-24086 Filed 12-14-05; 8:45 am]
BILLING CODE 3510-DS-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.